Novozymes A/S (OTCMKTS:NVZMY – Get Free Report) declared a dividend on Thursday, April 11th, NASDAQ reports. Shareholders of record on Thursday, May 2nd will be paid a dividend of 0.1853 per share by the biotechnology company on Monday, May 20th. The ex-dividend date is Wednesday, May 1st.
Novozymes A/S Stock Performance
Shares of NVZMY stock opened at $54.63 on Friday. The stock’s 50-day moving average is $56.62 and its two-hundred day moving average is $51.76. The firm has a market cap of $25.58 billion, a price-to-earnings ratio of 35.37, a PEG ratio of 3.80 and a beta of 0.82. Novozymes A/S has a 1 year low of $38.75 and a 1 year high of $61.86. The company has a debt-to-equity ratio of 0.30, a quick ratio of 0.80 and a current ratio of 1.30.
Novozymes A/S (OTCMKTS:NVZMY – Get Free Report) last issued its quarterly earnings data on Wednesday, January 31st. The biotechnology company reported $0.36 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.47 by ($0.11). Novozymes A/S had a return on equity of 21.42% and a net margin of 16.88%. The firm had revenue of $664.46 million for the quarter. Analysts predict that Novozymes A/S will post 1.93 earnings per share for the current year.
About Novozymes A/S
Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.
Featured Articles
- Five stocks we like better than Novozymes A/S
- Why Are Stock Sectors Important to Successful Investing?
- MarketBeat Week in Review – 4/8 – 4/12
- Trading Stocks: RSI and Why it’s Useful
- You Can Follow BlackRock’s Market View for Your Money
- Investing In Preferred Stock vs. Common Stock
- Breakout Alert: Coinbase’s Consolidation Is About To End
Receive News & Ratings for Novozymes A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novozymes A/S and related companies with MarketBeat.com's FREE daily email newsletter.